Vimarsana
Biggest News Aggregation in the World

Page 31 - Director John News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director John. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director John Today - Breaking & Trending Today

HC Wainwright Lowers Cytokinetics (NASDAQ:CYTK) Price Target to $90.00 - Vimarsana News

HC Wainwright Lowers Cytokinetics (NASDAQ:CYTK) Price Target to $90.00

Cytokinetics (NASDAQ:CYTK – Get Free Report) had its target price dropped by equities researchers at HC Wainwright from $94.00 to $90.00 in a research report issued on Thursday, Benzinga reports. The firm presently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s target price suggests a potential upside of 86.34% from the company’s […]

Saia, Inc. (NASDAQ:SAIA) Receives $497.22 Average PT from Brokerages - Vimarsana News

Saia, Inc. (NASDAQ:SAIA) Receives $497.22 Average PT from Brokerages

Saia, Inc. (NASDAQ:SAIA – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eighteen analysts that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and twelve have issued a buy recommendation on the […]

Cytokinetics (NASDAQ:CYTK) Shares Gap Down on Analyst Downgrade - Vimarsana News

Cytokinetics (NASDAQ:CYTK) Shares Gap Down on Analyst Downgrade

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) shares gapped down prior to trading on Thursday after Bank of America lowered their price target on the stock from $70.00 to $60.00. The stock had previously closed at $59.23, but opened at $49.25. Bank of America currently has a neutral rating on the stock. Cytokinetics shares last […]

Saia, Inc. (NASDAQ:SAIA) Receives Average Recommendation of "Moderate Buy" from Brokerages - Vimarsana News

Saia, Inc. (NASDAQ:SAIA) Receives Average Recommendation of "Moderate Buy" from Brokerages

Saia, Inc. (NASDAQ:SAIA – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eighteen analysts that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, six have given a hold rating and eleven have issued a buy rating on the company. The […]

Cytokinetics (NASDAQ:CYTK) Price Target Lowered to $72.00 at Needham & Company LLC - Vimarsana News

Cytokinetics (NASDAQ:CYTK) Price Target Lowered to $72.00 at Needham & Company LLC

Cytokinetics (NASDAQ:CYTK – Get Free Report) had its price objective reduced by equities researchers at Needham & Company LLC from $108.00 to $72.00 in a report released on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Needham & Company LLC’s price target would suggest a potential upside of […]